Improving the Cataract Patient Experience: Minimizing Pain and Inflammation while Reducing the Need for Topical Drops

Be the first to review this product

Availability: In stock

$0.00
    OR

    Quick Overview

    This activity is supported by educational grants from EyePoint Pharmaceuticals, Ocular Therapeutix, Omeros, and ImprimisRx. 
    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
    Activity Expiration Date: February 29, 2020

    Improving the Cataract Patient Experience: Minimizing Pain and Inflammation while Reducing the Need for Topical Drops

    Double click on above image to view full picture

    Zoom Out
    Zoom In

    More Views

    Details

    Description

    Enjoy this 60-minute CME activity in which a panel of experts discuss the improvement of pain and inflammation in the cataract patient. Topics include the impact of pain and inflammation, an overview of current and emerging approaches to minimize topical drops, and a discussion on reimbursement models.

    CME Information

    This activity is supported by educational grants from EyePoint Pharmaceuticals, Ocular Therapeutix, Omeros, and ImprimisRx.

    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.

    Activity Expiration Date: February 29, 2020

    Faculty: Eric D. Donnenfeld, MD; Alice T. Epitropoulos, MD; Edward J. Holland, MD; Denise M. Visco, MD; William F. Wiley, MD

    Learning Objectives

    Ophthalmologists who attend this course will:

    • Compare and contrast current and emerging regimens and pharmaceutical approaches for the prevention of pain and inflammation in cataract surgery, including alternative therapeutic options designed to overcome patient compliance concerns and reduce ocular toxicity
      • Advanced topical medications
      • Intracameral medications
      • Sustained release technologies
    • Determine adjustments needed to pre-, intra-, and postoperative steroid and NSAID regimens for patients at greater risk for inflammation
    • Discuss cataract patients’ perceptions of intra- and postoperative pain and the impact that it has on surgical outcomes and patient satisfaction
    • Describe evolving reimbursement models to expand access to new approaches to control pain and inflammation after cataract surgery